Founders Bay Holdings (FDBH) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Founders Bay Holdings (FDBH) trades at $0.0005 with AI Score 58/100 (Grade B). Founders Bay Holdings (FDBH) provides medical diagnostic services, focusing on the operation and administration of MRI equipment in diagnostic centers. Sector: Healthcare.
Price as of Jul 20, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for FDBH: FDBH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates FDBH against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
FDBH: 2/3 scored disciplines lean bullish. Dominant signal: Moon AI bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Founders Bay Holdings (FDBH) Healthcare & Pipeline Overview
Founders Bay Holdings, operating in the healthcare information services sector, specializes in medical diagnostic services through MRI equipment. Catering to HMOs and PPOs, the company, established in 1986, faces competition from larger healthcare providers while maintaining a strong profit margin of 43.2%.
What Is the Investment Thesis for FDBH?
Founders Bay Holdings (FDBH) presents a focused investment opportunity within the medical diagnostic services sector. The company's high profit margin of 43.2% and gross margin of 74.8% indicate operational efficiency. However, the company's small size, with only 7 employees, and its presence on the OTC market introduce liquidity and regulatory risks. Growth catalysts include potential expansion of MRI service offerings and strategic partnerships with healthcare providers. The negative beta of -4.75 suggests the stock may move inversely to the market. Investors should carefully consider the OTC market risks and limited information availability before investing. The absence of a dividend yield may deter income-focused investors.
Based on FMP financials and quantitative analysis
FDBH Key Highlights
- Profit Margin of 43.2% indicates strong operational efficiency within the medical diagnostic services niche.
- Gross Margin of 74.8% suggests effective cost management in providing MRI diagnostic services.
- Beta of -4.75 indicates a potential inverse correlation with the broader market, offering diversification benefits.
- Specialization in MRI diagnostic services allows FDBH to cater to specific needs of healthcare providers.
- Established in 1986, FDBH has a long operating history in the healthcare sector, demonstrating resilience.
Who Are FDBH's Competitors?
FDBH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CMHSF Comprehensive Healthcare Systems, Inc. | $0.34 | +0.00% | $6.22M | 55 |
| CRBKF Carebook Technologies Inc. | $0.03 | +0.00% | $6.84M | 64 |
| CMPD CompuMed, Inc. | $6.64 | +9.25% | $8.56M | 60 |
| BBLN Babylon Holdings Limited | $0.55 | -13.99% | $14.1M | 56 |
| THKKF Think Research Corporation | $0.23 | -1.74% | $17.8M | 57 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.1M | 67 |
| VRHI Veri Medtech Holdings Inc. | $2.00 | +43.88% | $40.0M | 67 |
| AIRDF Rocket Doctor AI Inc. | $0.45 | +4.82% | $43.2M | 56 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are FDBH's Key Strengths?
- High profit margin of 43.2%.
- Long operating history since 1986.
- Specialized expertise in MRI diagnostic services.
- Established relationships with healthcare providers.
What Are FDBH's Weaknesses?
- Small size with only 7 employees.
- Limited geographic reach.
- Reliance on MRI technology.
- Trades on the OTC market.
What Could Drive FDBH Stock Higher?
- Potential partnerships with healthcare providers to expand service reach.
- Expansion of MRI service offerings to include advanced diagnostic procedures.
- Continued focus on maintaining high profit margins through efficient operations.
- Leveraging established relationships with local healthcare providers.
What Are the Key Risks for FDBH?
- Limited liquidity due to trading on the OTC market.
- Increased competition from larger healthcare providers.
- Regulatory changes affecting the healthcare industry.
- Reliance on MRI technology, which could become obsolete.
- Limited financial disclosure due to OTC Other listing.
What Are the Growth Opportunities for FDBH?
- Expansion of MRI Service Offerings: FDBH can expand its service offerings by investing in advanced MRI technologies and specialized diagnostic procedures. The global MRI market is projected to reach $7.8 billion by 2027, driven by increasing prevalence of chronic diseases and technological advancements. By offering specialized MRI services, FDBH can attract new clients and increase revenue within the next 2-3 years.
- Strategic Partnerships with Healthcare Providers: Forming strategic partnerships with HMOs, PPOs, and other healthcare providers can provide FDBH with a steady stream of patients and revenue. The healthcare industry is increasingly focused on value-based care, which emphasizes collaboration and integrated services. By partnering with healthcare providers, FDBH can enhance its market reach and improve patient outcomes, with potential benefits materializing within the next 1-2 years.
- Geographic Expansion: FDBH can expand its operations to new geographic markets by establishing new diagnostic centers or acquiring existing facilities. The demand for MRI services is growing in emerging markets, driven by increasing healthcare spending and awareness. Expanding to new markets can diversify FDBH's revenue streams and reduce its reliance on the Las Vegas area, with potential expansion starting in the next 3-5 years.
- Telemedicine Integration: Integrating telemedicine solutions into its service offerings can allow FDBH to reach a wider patient base and improve access to diagnostic services. Telemedicine is experiencing rapid growth, driven by increasing adoption of digital health technologies and favorable regulatory changes. By offering remote MRI consultations and image analysis, FDBH can enhance its competitive advantage and attract tech-savvy patients, with integration potentially starting within the next 1-2 years.
- Data Analytics and Reporting: Leveraging data analytics to improve diagnostic accuracy and reporting can enhance FDBH's value proposition to healthcare providers. The healthcare industry is increasingly focused on data-driven decision-making, and providers are seeking solutions that can help them improve patient outcomes and reduce costs. By offering advanced data analytics and reporting capabilities, FDBH can differentiate itself from competitors and attract data-conscious clients, with implementation potentially starting within the next 1-2 years.
What Opportunities Does FDBH Have?
- Expansion of MRI service offerings.
- Strategic partnerships with healthcare providers.
- Geographic expansion to new markets.
- Integration of telemedicine solutions.
What Threats Does FDBH Face?
- Competition from larger healthcare providers.
- Technological advancements in diagnostic imaging.
- Regulatory changes in the healthcare industry.
- Economic downturn affecting healthcare spending.
What Are FDBH's Competitive Advantages?
- Established relationships with local healthcare providers.
- Specialized expertise in MRI diagnostic services.
- High profit margin indicating efficient operations.
- Long operating history since 1986.
What Does FDBH Do?
Founded in 1986 and based in Las Vegas, Nevada, Founders Bay Holdings (FDBH) operates within the medical diagnostic services industry. The company focuses on developing, operating, and administering magnetic resonance imaging (MRI) equipment in medical diagnostic centers. These centers provide crucial medical diagnostic services to a variety of healthcare organizations, including health maintenance organizations (HMOs), preferred provider organizations (PPOs), trade unions, clinics, and other healthcare providers. FDBH's business model centers around providing access to MRI technology and diagnostic services, enabling healthcare providers to offer advanced imaging capabilities to their patients. The company's services are essential for accurate and timely diagnoses, contributing to improved patient outcomes. While the company is relatively small, with only 7 employees, its high profit margin of 43.2% suggests efficient operations and a strong market position within its niche. Founders Bay Holdings navigates a competitive landscape, focusing on specialized service offerings to maintain its relevance and profitability in the healthcare sector.
What Products and Services Does FDBH Offer?
- Develops and operates magnetic resonance imaging (MRI) equipment.
- Administers MRI equipment in medical diagnostic centers.
- Provides medical diagnostic services to health maintenance organizations (HMOs).
- Offers diagnostic services to preferred provider organizations (PPOs).
- Serves trade unions with medical diagnostic services.
- Provides diagnostic services to clinics and other healthcare providers.
How Does FDBH Make Money?
- Generates revenue by providing MRI diagnostic services.
- Partners with healthcare providers to offer diagnostic imaging.
- Operates medical diagnostic centers equipped with MRI technology.
What Industry Does FDBH Operate In?
Founders Bay Holdings operates in the healthcare information services industry, which is experiencing growth due to increasing demand for diagnostic imaging and data-driven healthcare solutions. The market is competitive, with larger players like AOLS and AVTI offering a broader range of services. FDBH's focus on MRI diagnostic services allows it to carve out a niche, but it must adapt to evolving technology and regulatory changes. The industry is also influenced by trends such as telemedicine and remote patient monitoring, which could impact the demand for traditional diagnostic centers.
Who Are FDBH's Key Customers?
- Health maintenance organizations (HMOs).
- Preferred provider organizations (PPOs).
- Trade unions.
- Clinics.
- Other healthcare providers.
Company Profile
Founders Bay Holdings operates in the Information Technology Services industry within the Technology sector. It is headquartered in Las Vegas, US. The company is led by CEO Michael Jeremias Thomas. FDBH has traded publicly since 1995.
How Founders Bay Holdings Is Valued
Relative to its peer group, FDBH's quantitative score of 58/100 is roughly in line with the peer average of 58/100.
ROE 32%Key Financial Metrics
Return on equity for Founders Bay Holdings stands at 32.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 27.8%, showing how much profit it generates from its asset base. FDBH trades at a trailing price-to-earnings ratio of 0.00, below the Healthcare sector average of ~23x.
FDBH Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Founders Bay's future, indicating that leadership believes in the company's growth potential.
- Community sentiment has shifted positively, with discussions highlighting innovative projects and strategic partnerships that could enhance market position.
- Investors are increasingly optimistic about the company's focus on sustainable practices, aligning with broader market trends towards environmental responsibility.
- Positive news coverage has emphasized Founders Bay's adaptability in a changing market, reinforcing a bullish outlook among retail investors.
Bear Case
- Concerns have emerged regarding the company's cash flow management, with some investors questioning its ability to sustain operations without additional funding.
- Recent social sentiment indicates skepticism about the scalability of Founders Bay's business model, leading to mixed community opinions.
- Market perception has been affected by broader economic uncertainties, which could dampen investor enthusiasm for growth stocks like Founders Bay.
- Insider selling in the past month raised red flags among investors, creating doubts about the leadership's confidence in short-term performance.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
FDBH Latest News
No recent news available for FDBH.
FDBH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for FDBH.
Price Targets
Wall Street price target analysis for FDBH.
FDBH MoonshotScore
What does this score mean?
The MoonshotScore rates FDBH 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Jacob Simone
Managing
Jacob Simone is the managing leader of Founders Bay Holdings, overseeing a team of 7 employees. Information regarding his prior experience and educational background is not available. As the leader, Simone is responsible for the strategic direction, operational management, and financial performance of the company, which specializes in medical diagnostic services.
Track Record: Due to limited information, Jacob Simone's specific achievements and strategic decisions at Founders Bay Holdings are unknown. Assessing his track record is challenging without further data on company performance and key milestones during his tenure. His leadership is pivotal in navigating the competitive healthcare landscape and ensuring the company's continued operation.
FDBH OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Founders Bay Holdings may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Limited financial disclosure due to the OTC Other listing.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement.
- Lack of regulatory oversight compared to major exchanges.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Determine the company's ownership structure and shareholder base.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Long operating history since 1986.
- Specialized expertise in MRI diagnostic services.
- High profit margin of 43.2%.
- Physical headquarters in Las Vegas, Nevada.
Common Questions About FDBH (Healthcare)
What does the AI Score mean for FDBH?
FDBH holds an AI Score of 58/100 (Grade: B). This is an educational research signal, not a buy or sell recommendation. Founders Bay Holdings (FDBH) provides medical diagnostic services, focusing on the operation and administration of MRI equipment in diagnostic centers. The company caters to various healthcare …
What does Founders Bay Holdings do?
Founders Bay Holdings specializes in providing medical diagnostic services, primarily through the operation and administration of magnetic resonance imaging (MRI) equipment in medical diagnostic centers. The company caters to a variety of healthcare providers, including health maintenance organizations (HMOs), preferred provider organizations (PPOs), trade unions, clinics, and other healthcare entities.
What do analysts say about FDBH stock?
Due to the company's OTC listing and limited analyst coverage, there is no readily available analyst consensus on Founders Bay Holdings. Key valuation metrics include a P/E ratio of 0.0, reflecting the company's earnings, and a profit margin of 43.2%, indicating strong profitability.
What are the main risks for FDBH?
Founders Bay Holdings faces several risks, including limited liquidity due to its trading on the OTC market, which can make it difficult to buy or sell shares. The company also faces competition from larger healthcare providers with greater resources and broader service offerings. Regulatory changes in the healthcare industry could impact the company's operations and profitability.
What are the key factors to evaluate for FDBH?
Founders Bay Holdings (FDBH) holds an AI score of 58/100 (moderate). P/E: 0.0x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does FDBH data refresh on this page?
FDBH's price was last updated on Jul 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven FDBH's recent stock price performance?
Founders Bay Holdings (FDBH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: High profit margin of 43.2%. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider FDBH overvalued or undervalued right now?
Founders Bay Holdings (FDBH) trades at 0.0x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research FDBH before investing?
Before investing in Founders Bay Holdings (FDBH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is limited due to the company's OTC listing and lack of analyst coverage.
- Financial data is based on available information and may not be comprehensive.
- OTC market investments carry higher risks than exchange-listed securities.